As we look forward to a healthier, brighter 2021, we are excited to share key information about the #COVID19Nigeria vaccine.
Come with us.
COVID-19 is the infectious disease caused by the most recently discovered coronavirus, known as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This new virus and disease were unknown before the outbreak began in Wuhan, China, in December 2019.
The most common symptoms of COVID-19 are fever, tiredness, dry cough, and difficulty in breathing. Some patients may have body aches and pains, loss of smell, nasal congestion, runny nose, sore throat, or diarrhea.
These symptoms usually start mildly and gradually become serious. Some people become infected but do not develop any symptoms and do not feel unwell. Most people (about 80%) recover from the disease without needing hospitalization.
Around 1 out of every 6 people who get COVID-19 becomes seriously ill and develops difficulty in breathing. Older people, and those with underlying medical conditions like high blood pressure, heart problems, cancer, or diabetes, are more likely to develop serious illness.
COVID-19 vaccines aim to prevent COVID-19 disease by triggering an immune response.
COVID-19 vaccines are being developed following the same legal requirements for quality, safety, and efficacy as for all other vaccines.
Like all vaccines, the effects of COVID-19 vaccines are tested first in the laboratory, including in animals, and then in human volunteers.
The National Regulatory Authority, such as NAFDAC, is the agency in charge of evaluation and supervision of medicinal products.
It will evaluate COVID-19 vaccines against the same high standards as for all other vaccines before they can be released for use.
NAFDAC will continually monitor side effects in people who have received COVID-19 vaccines and identify and evaluate new information that arises on the benefits and safety of COVID-19 vaccines promptly.
Why should I get vaccinated for COVID-19?
It is strongly recommended that you get vaccinated against COVID-19. The vaccine will protect you from getting infected, sick, or dying. By getting vaccinated, you also protect your loved ones and your community.
Nigeria plans to introduce the COVID-19 vaccine in the 1st Quarter of 2021 to halt the ongoing spread of the virus and to save lives. Once the vaccine is available, there will be public announcements on when and where to get the vaccine ‼️
No! the vaccine cannot infect you with COVID-19. It is meant to protect you from COVID -19 infection. Once your vaccination doses are complete, you become protected.
Yes. NPHCDA recommends that you get vaccinated even if you have already had COVID-19, because you can be infected more than once. While you may have some short-term antibody protection after recovering from COVID-19, we do not know how long this protection will last.
While you may have some short-term antibody protection after recovering from COVID-19, we do not know how long this protection will last. Hence, it is recommended that that you get vaccinated because you can be re-infected.
Can pregnant and lactating mothers receive the vaccine?
NO! Studies are yet to be conducted to ascertain the safety of the vaccine on pregnant and lactating mothers.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
PSA: FEDERAL GOVERNMENT RESPONSE TO THE DELTA STATE YELLOW FEVER OUTBREAK IN COLLABORATION WITH THE STATE GOVERNMENT AND PARTNERS.
On 30th October 2020, an outbreak of a mysterious illness was reported from Idumesah ward, Ika North East LGA of Delta state, south south, Nigeria. Idumesah, Ute-Okpu and Owa Oyigbo wards are the most affected of the seven (7) wards in the LGA that have recorded cases.
Date of onset of the first illness was 24th July, second reported case was 29th July and third was 23rd September, 2020.
INTRODUCING MEASLES SECOND DOSE AT 15 MONTHS INTO THE ROUTINE IMMUNIZATION SCHEDULE
Dear Nigerians.
From the 14th of November 2019, the Federal Government will be introducing Measles Second Dose at 15 Months into the Routine Immunization schedule.
Apart from the usual first dose of Measles at nine (9) months old, all children will be vaccinated at 15 months with a SECOND DOSE of Measles vaccine.
The SECOND DOSE of Measles vaccination is given to every child at 15 months as a second opportunity to fully protect children against the deadly Measles disease.
The NPHCDA is introducing a SECOND DOSE of measles vaccine into the routine immunization (RI) programme. This intervention is primarily aimed at providing a second dose of measles vaccine to the children who are highly susceptible to measles.
In addition,it offers an opportunity to initiate 1st dose measles vaccination for children who might have missed in their 1st year of life or failed to seroconvert & provides an opportunity to integrate other services with immunization during the 2nd year of life for the children
Measles is an acute & highly infectious disease caused by the measles virus. It is one of the leading causes of morbidity & mortality among children under years old. Globally, an estimated 246 children die each day from measles, the majority of whom are from Africa, including 🇳🇬
As part of FG commitment to implement the Basic Health Care Provision Fund (BHCPF), the sum of N55b representing 1% consolidated federal revenue was appropriated in 2018 budget and the sum of N12.7b released so far for implementation.
Of the amount available in the BHCPF, 45% is to be channeled by the NPHCDA i.e. the NPHCDA Gateway to at least ONE eligible PHC facility per geopolitical ward through the SPHCB.
On the 20th of May, 2019, the NPHCDA TSA Account was credited with N5.89b representing 45% of 12.7b. for implementation in 19 states which had been cleared for participation by the National Steering Committee of the BHCPF.